4//SEC Filing
McIlvenny Patrick 4
Accession 0001209191-23-002440
CIK 0001492426other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:56 PM ET
Size
15.7 KB
Accession
0001209191-23-002440
Insider Transaction Report
Form 4
McIlvenny Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2023-01-05+7,973→ 10,463 total - Tax Payment
Ordinary Shares
2023-01-05$113.24/sh−4,147$469,606→ 6,316 total - Award
Restricted Stock Units (RSU)
2023-01-04+11,498→ 11,498 total→ Ordinary Shares (11,498 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−3,871→ 0 total→ Ordinary Shares (3,871 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−2,198→ 2,198 total→ Ordinary Shares (2,198 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−1,904→ 3,809 total→ Ordinary Shares (1,904 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
- [F3]The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
- [F4]The remaining ordinary shares subject to the RSU vest on January 5, 2024.
- [F5]The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001952703
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:56 PM ET
- Size
- 15.7 KB